Antibiotice S.A. (BVB:ATB)
1.834
+0.036 (2.00%)
At close: Apr 8, 2026
Antibiotice Market Cap
Antibiotice has a market cap or net worth of 1.21 billion as of April 8, 2026. Its market cap has decreased by -21.48% in one year.
Market Cap
1.21B
Enterprise Value
1.43B
Revenue
660.04M
Ranking
n/a
PE Ratio
23.32
Stock Price
1.83
Market Cap Chart
Since December 20, 2004, Antibiotice's market cap has increased from 202.01M to 1.21B, an increase of 497.54%. That is a compound annual growth rate of 8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 1.21B | -26.61% |
| Dec 30, 2025 | 1.64B | -4.30% |
| Dec 30, 2024 | 1.72B | 83.51% |
| Dec 29, 2023 | 936.52M | 146.47% |
| Dec 30, 2022 | 379.98M | -6.60% |
| Dec 30, 2021 | 406.83M | 24.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fondul Proprietatea | 1.63B |
| Infinity Capital Investments | 1.53B |
| Aerostar | 1.51B |
| Teraplast | 1.38B |
| Sphera Franchise Group | 1.38B |
| Biofarm | 1.23B |
| Transilvania Investments Alliance | 1.20B |
| Green Tech International | 1.02B |